Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling

(2018) Jeanne S. Mandelblatt et al.   MEDICAL DECISION MAKING

The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update

(2018) Oguzhan Alagoz et al.   MEDICAL DECISION MAKING

Structure, Function, and Applications of the Georgetown–Einstein (GE) Breast Cancer Simulation Model

(2018) Clyde B. Schechter et al.   MEDICAL DECISION MAKING

Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia

(2018) Jeroen J. van den Broek et al.   MEDICAL DECISION MAKING

Whose Preferences Matter? A Patient-Centered Approach for Eliciting Treatment Goals

(2017) Nananda F. Col et al.   MEDICAL DECISION MAKING

A Bayesian Simulation Model for Breast Cancer Screening, Incidence, Treatment, and Mortality

(2017) Xuelin Huang et al.   MEDICAL DECISION MAKING

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

(2016) Jeanne S. Mandelblatt et al.   ANNALS OF INTERNAL MEDICINE

Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ

(2016) Oyewale O. Shiyanbola et al.   CANCER

Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review

(2016) Nereo Segnan et al.   INTERNATIONAL JOURNAL OF CANCER

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study

(2016) Stephen W Duffy et al.   LANCET ONCOLOGY

The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age-Period-Cohort Model

(2015) R. E. Gangnon et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ

(2015) A. Francis et al.   CLINICAL ONCOLOGY

Addressing overtreatment of screen detected DCIS; the LORIS trial

(2015) Adele Francis et al.   EUROPEAN JOURNAL OF CANCER

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study

(2015) Lotte E. Elshof et al.   EUROPEAN JOURNAL OF CANCER

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ

(2015) Yasuaki Sagara et al.   JAMA Surgery

Rethinking the Standard for Ductal Carcinoma In Situ Treatment

(2015) Laura Esserman et al.   JAMA Oncology

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ

(2015) Steven A. Narod et al.   JAMA Oncology

Quantifying the natural history of breast cancer

(2013) K H X Tan et al.   BRITISH JOURNAL OF CANCER

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

(2013) L. J. Solin et al.   JNCI-Journal of the National Cancer Institute

Characterizing the impact of 25 years of DCIS treatment

(2011) Elissa M. Ozanne et al.   BREAST CANCER RESEARCH AND TREATMENT

Improvement in DCIS Detection Rates by MRI Over Time in a High-Risk Breast Screening Study

(2011) Ellen Warner et al.   Breast Journal

Interpreting Overdiagnosis Estimates in Population-based Mammography Screening

(2011) R. de Gelder et al.   EPIDEMIOLOGIC REVIEWS

National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009

(2010) C. J. Allegra et al.   JNCI-Journal of the National Cancer Institute

Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes

(2010) B. A. Virnig et al.   JNCI-Journal of the National Cancer Institute

Why Do Purely Intraductal Cancers Enhance on Breast MR Images?

(2009) Christiane K. Kuhl   RADIOLOGY

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

(2008) Inger Kristin Larsen et al.   EUROPEAN JOURNAL OF CANCER